Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06341530
Status:
RECRUITING
Last Update Posted:
2024-04-02
First Post:
2024-03-12
Brief Title:
Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer
Sponsor:
The First Affiliated Hospital of Zhengzhou University
Organization:
The First Affiliated Hospital of Zhengzhou University
Organization Data
Organization:
The First Affiliated Hospital of Zhengzhou University
Class:
OTHER
Study ID:
SURPASS-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The First Affiliated Hospital of Zhengzhou University
Lead Sponsor Class:
OTHER
Responsible Party:
Chengzhe
Responsible Party Title:
Chief physician
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
The First Affiliated Hospital of Zhengzhou University
Old Name:
None
Old Organization:
None